This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
A look at the use of ELIQUIS, Xarelto, and other blood thinners for cardiovascular disease and atrial fibrillation
Ticker(s): BMY, JNJ, BAYN.XSWXWho's the expert?
Institution: Cardiovasvular Insutitute of the South
- Joined CIS in 2017 as an interventional cardiologist in Opelousas.
- Attended Loyola University Chicago Stritch School of Medicine in Maywood, Illinois. Completed an internship and residency in internal medicine.
- Continued his training at Ochsner Medical Center in New Orleans and served as chief cardiology fellow and was named cardiology fellow of the year.
- Attended Scripps Green in La Jolla, California to train in interventional cardiology.
- Has written and published multiple presentations and medical book reviews.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
